Search filters

List of works by Scott A Van Wart

1388. Dose Discrimination for ASN100: Bridging from Rabbit Survival Data to Predicted Activity in Humans Using a Minimal Physiologically Based Pharmacokinetic (mPBPK) Model

article published in 2018

1408. Population Pharmacokinetic (PK) Model to Describe Epithelial Lining Fluid (ELF) Penetration of ASN-1 and ASN-2 after ASN100 Administration to Healthy Subjects

article by Scott A Van Wart et al published November 2018 in Open Forum Infectious Diseases

398Pharmacokinetics of dalbavancin (DAL) in bone and associated tissues in patients undergoing orthopedic surgical procedures

scientific article published in December 2014

A Phase 1 Study of Intravenous Plazomicin in Healthy Adults to Assess Potential Effects on the QT/QTc Interval, Safety, and Pharmacokinetics

scientific article published on 16 January 2019

A Phase 1 Study to Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function

scholarly article by Allison S Komirenko et al published 1 October 2018 in Antimicrobial Agents and Chemotherapy

Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci

scientific article published in February 2009

Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization.

scientific article published on 19 August 2013

Correction to: PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside

scientific article published on 14 February 2018

Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.

scientific article published on 14 December 2015

Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a 'Goldilocks' window

scientific article published on 28 June 2017

Extended-duration dosing and distribution of dalbavancin into bone and articular tissue

scientific article

Impact of dose selection on parameter estimation using a rapid binding approximation model of target-mediated drug disposition ⬇️

scientific article published on December 17, 2010

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes

scientific article

Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia

scientific article published on 27 July 2009

PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside

scientific article published on 28 March 2017

Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection Following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multi-Center Study (ACUMIN)

scientific article published on 09 November 2020

Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia

scientific article published on 16 September 2013

Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections

scientific article

Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients.

scientific article published on 26 February 2009

Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae

scientific article published on 25 November 2013

Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data

scientific article published on 27 April 2020

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

scientific article published on 27 March 2019

Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy

scientific article

Population Pharmacokinetics of Oseltamivir: Pediatrics through Geriatrics ⬇️

scientific article published on May 13, 2013

Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections

scientific article published on December 2004

Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community‐acquired bacterial pneumonia ⬇️

scientific article published on August 14, 2013

Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosis ⬇️

scientific article published on 06 August 2013

Population-based meta-analysis of furosemide pharmacokinetics.

scientific article

Population-based meta-analysis of hydrochlorothiazide pharmacokinetics

scientific article published on 10 October 2013

Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis

scientific article

Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints

scientific article published in January 2009

Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis

scientific article

Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia

scientific article

Paulina is supported by:

About Paulina

Help